Cart
sales@molnova.com
(1S,2S)-Bortezomib
CAS No. 1132709-14-8
(1S,2S)-Bortezomib( Bortezomib )
Catalog No. M26020 CAS No. 1132709-14-8
(1S,2S)-Bortezomib is an enantiomer of Bortezomib. Bortezomib is a reversible and selective inhibitor of the proteasome with a Ki of 0.6 nM for 20S proteasome.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 133 | In Stock |
|
| 5MG | 258 | In Stock |
|
| 10MG | 447 | In Stock |
|
| 25MG | 716 | In Stock |
|
| 50MG | 972 | In Stock |
|
| 100MG | 1305 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(1S,2S)-Bortezomib
-
NoteResearch use only, not for human use.
-
Brief Description(1S,2S)-Bortezomib is an enantiomer of Bortezomib. Bortezomib is a reversible and selective inhibitor of the proteasome with a Ki of 0.6 nM for 20S proteasome.
-
Description(1S,2S)-Bortezomib is an enantiomer of Bortezomib. Bortezomib is a reversible and selective inhibitor of the proteasome with a Ki of 0.6 nM for 20S proteasome.(In Vitro):Bortezomib disrupts the cell cycle, induces apoptosis, inhibits NF-κB, and possesses anti-cancer capacity.
-
In Vitro——
-
In Vivo——
-
SynonymsBortezomib
-
PathwayProteasome/Ubiquitin
-
TargetProteasome
-
RecptorNon-cleavable
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1132709-14-8
-
Formula Weight384.24
-
Molecular FormulaC19H25BN4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (130.13 mM)
-
SMILES[C@H](CC1=CC=CC=C1)(C(N[C@H](CC(C)C)B(O)O)=O)NC(=O)C=2C=NC=CN2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pyrrolobenzodiazepine Dimer Antibody-Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers. J Med Chem. 2017 Dec 14;60(23):9490-9507.
molnova catalog
related products
-
PSI
PSI is a proteasome inhibitor.
-
VR-23
A potent inhibitor of trypsin-like proteasome (IC50=1 nM), chymotrypsin-like proteasome (IC50=50-100 nM) and caspase-like proteasome (IC50=3 uM).
-
Delanzomib
A potent, orally active proteasome inhibitor with IC50 of 3.8 nM against chymotrypsin-like proteasome activity.
